Hot Features
Premium
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Zeitraum:
Zeichenmodus:
| Volumen | 28.335 |
|
|||||
| News | - | ||||||
| Tageshoch | 3,27 | Niedrig Hoch |
|||||
| Tagestief | 3,1014 | ||||||
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| MyMD Pharmaceuticals Inc | MYMD | NASDAQ | Common Stock |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| 0,05 | 1,56% | 3,25 | 00:44:35 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 3,27 | 3,1014 | 3,27 | 3,25 | 3,20 |
| Trades | Volumen | VWAP | Finanzielles Volumen | Durchsch. Volumen | 52 Week Range |
|---|---|---|---|---|---|
| 258 | 28.335 | US$ 3,19 | US$ 90.264 | - | 2,00 - 70,50 |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| 22:20:47 | 47 | US$ 3,3998 | USD |
Finanzwerte MYMD
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 6,8M | 2,09M | - | 0 | -8,22M | -3,93 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News MyMD Pharmaceuticals
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 07.3.2024 | 22:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 05.3.2024 | 17:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 05.3.2024 | 15:15 | Business Wire | MyMD Pharmaceuticals Regains Compliance with Nasdaq Minimum.. |
| 14.2.2024 | 21:13 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
| 14.2.2024 | 17:27 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 13.2.2024 | 22:57 | Edgar (US Regulatory) | Form 8-K - Current report |
| 13.2.2024 | 17:45 | Business Wire | MyMD Pharmaceuticals Announces Reverse Stock Split to.. |
| 06.12.2023 | 15:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 06.12.2023 | 15:15 | Business Wire | MyMD Pharmaceuticals Plans FDA-Cleared Phase 2 Clinical.. |
| 19.10.2023 | 15:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 19.10.2023 | 15:00 | Business Wire | MyMD Announces Preclinical Study Results Showing Novel.. |
| 13.10.2023 | 23:00 | Edgar (US Regulatory) | Form 8-K - Current report |
Forum MyMD Pharmaceuticals
Keine Diskussionen Gefunden.Neuen Thread Erstellen
MYMD Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 2,79 | 3,36 | 2,74 | 3,08 | 59.289 | 0,46 | 16,49% |
| 1 Monat | 2,25 | 3,50 | 2,00 | 2,62 | 628.150 | 1,00 | 44,44% |
| 3 Monate | 3,999 | 4,50 | 2,00 | 3,08 | 354.072 | -0,749 | -18,73% |
| 6 Monate | 11,40 | 12,0615 | 2,00 | 6,57 | 971.746 | -8,15 | -71,49% |
| 1 Jahr | 58,50 | 70,50 | 2,00 | 18,10 | 813.799 | -55,25 | -94,44% |
| 3 Jahre | 128,70 | 298,50 | 2,00 | 52,44 | 418.069 | -125,45 | -97,47% |
| 5 Jahre | 162,90 | 298,50 | 2,00 | 57,57 | 436.395 | -159,65 | -98,00% |
